Regulated information
In accordance with the requirements of Article 14 of the Belgian Law of May 2, 2007 on the disclosure of significant shareholdings in listed companies, Ontex Group NV (“Ontex”) discloses the notifications of significant shareholding by the Goldman Sachs Group, Inc.
On August 12, 2026, Ontex received a transparency declaration confirming that, on August 6, 2026, the Goldman Sachs Group, Inc., detained 384,594 Ontex voting rights and 2,112,669 equivalent financial instruments or 2,497,263 combined, representing respectively 0.47%, 2.57% and 3.03% of Ontex’s issued shares. The combined holding thereby crossed upward the threshold of 3%.
On August 14, 2026, Ontex received a transparency declaration confirming that, on August 7, 2026, the Goldman Sachs Group, Inc., detained 342,842 Ontex voting rights and 1,825,395 equivalent financial instruments or 2,168,237 combined, representing respectively 0.42%, 2.22% and 2.63% of Ontex’s issued shares. The combined holding thereby crossed downward the threshold of 3%.
Enquiries
| Investors | Geoffroy Raskin | +32 53 333 730 | investor.relations@ontexglobal.com |
| Media | Catherine Weyne | +32 53 333 622 | corporate.communications@ontexglobal.com |
About Ontex
Ontex is a leading international developer and producer of baby care, feminine care and adult care products, both for retailers and healthcare, primarily in Europe and North America. The group employs around 5,000 people, with plants and offices in 12 countries, and its innovative products are distributed in around 100 countries. Ontex is headquartered in Aalst, Belgium and is listed on Euronext Brussel. To keep up with the latest news, visit ontex.com or follow Ontex on LinkedIn.
ONTEX Group NV
Korte Keppestraat 21 – 9320 Erembodegem (Aalst) – Belgium 0550.880.915 RPR Ghent – Division Dendermonde
Attachment
